Understanding the Complexities of Osteoporosis and Impact on the Health Care System

Understanding the Complexities of Osteoporosis and Impact on the Health Care System

Faculty Presenter

Danielle Fixen, PharmD, BCGP, BCPS
Assistant Professor
Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado
 
Program Description
In the United States, more than 50% of adults older than 50 years have either low bone mass or diagnosed osteoporosis. Osteoporosis affects nearly 4 times as many women than men, in part due to estrogen deficiencies that occur during and after menopause in women. All individuals can be at increased risk for osteoporosis, as factors leading to low bone density can also be related to nutrition, such as insufficient calcium or vitamin D intake, substance use or cigarette smoking, and inadequate physical activity. Osteoporosis can occur due to a multitude of causes, and screening for the condition by physical exam or risk assessment with a fracture risk assessment tool should be utilized in older adult patients. This is the first module in the 4-part curriculum series and outlines the role of the pharmacist in identifying patients who would most benefit from osteoporosis prevention and screening. 

Target Audience: Specialty pharmacists
Type of Activity: Application
Release date: March 31, 2021
Expiration date: March 31, 2022
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Classify the epidemiology, etiology, and pathophysiology of osteoporosis
• Characterize the clinical and economic burden of osteoporosis
• Examine evidence-based screening and diagnostic recommendations for osteoporosis

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-011-H01-P. The activity is available for CE credit through March 31, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Danielle Fixen, PharmD, BCGP, BCPS, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Michelle Carlson, PharmD; Brianna Schauer, MBA, PMP; Kelly McCormick; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms